http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-40977-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2de3beee83d9c19278da409b72c777a8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-935 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-935 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-12 |
| filingDate | 1975-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1979-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-40977-B1 |
| titleOfInvention | Prostaglandin compositions |
| abstract | 1484591 Compositions containing prostaglandins ONO PHARMACEUTICAL CO Ltd 10 April 1975 [11 April 1974] 16242/74 Heading A5B [Also in Divisions C2 and C3] A composition for the production of an oxytocic, abortifacient, post-labour placental expulsion, contraceptive or menstruation-inducing effect in female mammals comprises (1) a PGF 1 α compound, a dihydro-PGF 1 α compound, a PGF 2 α compound or a 13, 14- dihydro-PGF 2 α compound characterised, by the presence of an alicyclic ring of the formula:- and by the presence of (a) a trans-double bond between C 13 -C 14 and an ethylene group in C 5 -C 6 , or (b) ethylene groups in C 5 -C 6 and C 13 -C 14 , or (c) a cis-double bond between C 5 -C 6 and a trans-double bond between C 13 -C 14 , or (d) a cis-double bond between C 5 -C 6 and an ethylene group in C 13 -C 14 , in association with (2) a PGE 1 compound, a dihydro-PGE 1 compound, a PGE 2 compound or a 13, 14-dihydro-PGE 2 compound characterised by the presence of an alicyclic ring of the formula:- and by the presence of (a) a trans-double bond between C 13 -C 14 and an ethylene group in C 5 -C 6 or (b) ethylene groups in C 5 -C 6 and C 13 -C 14 , or (c) a cis-double bond between C 5 -C 6 and a trans-double bond between C 13 -C 14 or (d) a cis-double bond between C 5 -C 6 and an ethylene group in C 13 -C 14 .n[GB1484591A] |
| priorityDate | 1974-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.